(Q33916137)

30 July 2017

1 reference

title

Oligonucleotide N3'-->P5' phosphoramidates as potential therapeutic agents (English)

1 reference

30 July 2017

S M Gryaznov

1

1 reference

PubMed ID

10807003

30 July 2017

language of work or name

English

0 references

publication date

1 December 1999

1 reference

30 July 2017

10

1 reference

Biochimica et Biophysica Acta

inferred from page(s)

published in

1 reference

30 July 2017

1489

1 reference

30 July 2017

131-140

1 reference

30 July 2017

1

1 reference

Specific regulation of gene expression by antisense, sense and antigene nucleic acids

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2899%2900151-7

7 January 2021

Antisense oligonucleotides: a new therapeutic principle

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2899%2900151-7

7 January 2021

Ribozymes as human therapeutic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2899%2900151-7

7 January 2021

A general purpose RNA-cleaving DNA enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2899%2900151-7

7 January 2021

RNA-catalysed nucleotide synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2899%2900151-7

7 January 2021

Potent 2'-amino-, and 2'-fluoro-2'-deoxyribonucleotide RNA inhibitors of keratinocyte growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2899%2900151-7

7 January 2021

Oligonucleotide N3'-->P5' phosphoramidates

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2899%2900151-7

7 January 2021

Oligo-2'-fluoro-2'-deoxynucleotide N3'-->P5' phosphoramidates: synthesis and properties

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2899%2900151-7

7 January 2021

RNA mimetics: oligoribonucleotide N3'-->P5' phosphoramidates

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2899%2900151-7

7 January 2021

Synthesis of oligodeoxyribonucleotide N3'-->P5' phosphoramidates

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2899%2900151-7

7 January 2021

An oligodeoxyribonucleotide N3'--> P5' phosphoramidate duplex forms an A-type helix in solution

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2899%2900151-7

7 January 2021

NMR solution structure of the N3' --> P5' phosphoramidate duplex d(CGCGAATTCGCG)2 by the iterative relaxation matrix approach

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2899%2900151-7

7 January 2021

Structural RNA mimetics: N3'-->P5' phosphoramidate DNA analogs of HIV-1 RRE and TAR RNA form A-type helices that bind specifically to Rev and Tat-related peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2899%2900151-7

7 January 2021

Stable triple helices formed by oligonucleotide N3'-->P5' phosphoramidates inhibit transcription elongation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2899%2900151-7

7 January 2021

Efficient inhibition of transcription elongation in vitro by oligonucleotide phosphoramidates targeted to proviral HIV DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2899%2900151-7

7 January 2021

Accessibility of nuclear DNA to triplex-forming oligonucleotides: the integrated HIV-1 provirus as a target

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2899%2900151-7

7 January 2021

A physico-chemical study of triple helix formation by an oligodeoxythymidylate with N3'--> P5' phosphoramidate linkages

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2899%2900151-7

7 January 2021

Stability and Properties of Double and Triple Helices: Dramatic Effects of RNA or DNA Backbone Composition

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2899%2900151-7

7 January 2021

Oligo(2'-O-methyl)ribonucleotides. Effective probes for duplex DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2899%2900151-7

7 January 2021

Nucleoside conformation is determined by the electronegativity of the sugar substituent.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2899%2900151-7

7 January 2021

Exclusion of RNA strands from a purine motif triple helix

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2899%2900151-7

7 January 2021

Oligonucleotide N3'-->P5' phosphoramidates as antisense agents

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2899%2900151-7

7 January 2021

Analysis of a ribonuclease H digestion of N3'-->P5' phosphoramidate-RNA duplexes by capillary gel electrophoresis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2899%2900151-7

7 January 2021

RNase H-independent antisense activity of oligonucleotide N3 '--> P5 ' phosphoramidates.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2899%2900151-7

7 January 2021

Antileukemia effect of c-myc N3'-->P5' phosphoramidate antisense oligonucleotides in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2899%2900151-7

7 January 2021

10.1016/S0167-4781(99)00151-7

Identifiers

DOI

1 reference

release_qu7dnqi5avhgtpvf4bfrkum3gm

30 July 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/qu7dnqi5avhgtpvf4bfrkum3gm

24 November 2022

mapped directly with Wikidata item

PubMed ID

10807003

1 reference

PubMed ID

10807003